17 news items
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
AAWH
ASPI
ATRA
12 Jun 24
slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
AAWH
ASPI
ATRA
11 Jun 24
slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
ICU
10 Jun 24
risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside SeaStar
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU
7 Jun 24
and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected
SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
ICU
6 Jun 24
results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult to predict
e59j13rr24p9vm9djopugur100z1gmyl0z3085lxr8ul
ICU
6 Jun 24
cause the actual results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult
plbikcb0q1n88s0nlhutot11dnjhxe3ijpei5by1t5l9qtftlbydd
ICU
14 May 24
and assumptions and, as a result, are subject to significant risks and uncertainties that could cause the actual results to differ materially from the expected
qch 8s1fqfas18mjgmmdif77bzgeb9nwq6s8g7jjwg3vlp1w
ICU
28 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
w6prc1
ICU
24 Apr 24
Officer stated that "[t]he restatement is not expected to have a material impact on [the Company's] business operations or our cash position, but rather
4wc0564utqir1vdvl1sekui8km5tb15r0dlfqw
ICU
20 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
vowvef8z6i1atfdmv1pska1
ICU
17 Apr 24
the actual results to differ materially from the expected results. Most of these factors are outside SeaStar Medical's control and are difficult to predict
65bb5txqna2v xstyv6xi
ICU
16 Apr 24
restatement is not expected to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting
i0aa7 mxl2xv0kxkaoml2
ICU
12 Apr 24
to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting of non-cash accounting
2pe53ylu2
ICU
8 Apr 24
to have a material impact on [the Company's] business operations or our cash position, but rather is related to the reporting of non-cash accounting
ioh2yu6dragigfdqc6 tt7v9xeq
ICU
4 Apr 24
in June 2023. Further, SeaStar's Chief Executive Officer stated that "[t]he restatement is not expected to have a material
0h43qdo3j9e6x7ztmif40 hvzqqx
ICU
28 Mar 24
Executive Officer stated that "[t]he restatement is not expected to have a material impact on [the Company's] business operations or our cash
d7ik45q63sstu3abgig19f5v45mopdalx8in8t3nkadchgz6kg6k61o
ICU
27 Mar 24
items is not expected to materially impact cash position or operations DENVER, March 27, 2024 (GLOBE NEWSWIRE
- Prev
- 1
- Next